L. Rosenthal

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

G. Silvestri, R. Osarogiagbon, Caroline Schenkel, 2021, Cancer medicine.

Characteristics of Persons Screened for Lung Cancer in the United States

E. Kazerooni, P. Mazzone, N. Tanner, 2022, Annals of Internal Medicine.

Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide

G. Silvestri, R. Osarogiagbon, M. Nishino, 2023, CA: a cancer journal for clinicians.

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.

J. Jett, G. Silvestri, R. Osarogiagbon, 2020, Chest.

Melanoma awareness and self-examination practices: results of a United States survey.

D. Rigel, R. Lew, C. Cockerell, 1996, Journal of the American Academy of Dermatology.

Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States

E. Kazerooni, S. Fedewa, Robert A Smith, 2022, Cancer.

Outcomes from more than a million persons screened for lung cancer with low-dose computed tomography.

E. Kazerooni, P. Mazzone, N. Tanner, 2023, Chest.

DERM/INFONET: a concept becomes a reality.

A. Kopf, D. Rigel, W. Jordan, 1988, Journal of the American Academy of Dermatology.